Galecto, Inc. (DMRA) vs Ocular Therapeutix, Inc. (OCUL)
- Galecto, Inc. DMRA 23.67 +8.28%
- Ocular Therapeutix, Inc. OCUL 6.62 +2.95%
Galecto, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Galecto, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.4B and $1.4B). Ocular Therapeutix, Inc. has negative trailing earnings, so its P/E is not meaningful; Galecto, Inc. trades at 24.7×. Galecto, Inc. has the higher net margin (0.00% vs −579.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Galecto, Inc. leads on 10 and Ocular Therapeutix, Inc. on 3.
Valuation
Profitability
| Metric | DMRA | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 87.11% | 68.51% |
| Operating margin | 0.00% | (603.04%) | 0.00% |
| Net margin | 0.00% | (579.10%) | 0.00% |
| Free cash flow margin | 0.00% | (490.07%) | 0.00% |
| Return on equity | (39.51%) | (72.99%) | (51.96%) |
| Return on assets | (27.08%) | (53.70%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack